ロード中...

Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway

BACKGROUND: Diabetic nephropathy (DN) is the leading cause of end-stage renal failure, contributing to severe morbidity and mortality in diabetic patients. Berberine (BBR) has been well characterized to exert renoprotective effects in DN progression. However, the action mechanism of BBR in DN remain...

詳細記述

保存先:
書誌詳細
出版年:Biol Res
主要な著者: Zhu, Liping, Han, Jiakai, Yuan, Rongrong, Xue, Lei, Pang, Wuyan
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5878418/
https://ncbi.nlm.nih.gov/pubmed/29604956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40659-018-0157-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!